The heme in lactoperoxidase is attached to the protein by ester bonds between the heme 1-and 5-methyl groups and Glu-375 and Asp-275, respectively. To investigate the cross-linking process, we have examined the D225E, E375D, and D225E/E375D mutants of bovine lactoperoxidase. The heme in the E375D mutant is only partially covalently bound, but exposure to H 2 O 2 results in complete covalent binding and a fully active protein. Digestion of this mutant shows that the heme is primarily bound through its 5-methyl group. Excess H 2 O 2 increases the proportion of the doubly linked species without augmenting enzyme activity. The D225E mutant has little covalently bound heme and a much lower activity, neither of which are significantly increased by the addition of heme and H 2 O 2 . The heme is linked to this protein through a single bond to the 1-methyl group. The D225E/E375D mutant has no covalently bound heme and no activity. A small amount of iron 1-hydroxymethylprotoporphyrin IX is obtained from the wild-type enzyme along with the predominant dihydroxylated derivative. The results establish that a single covalent link suffices to achieve maximum catalytic activity and suggest that the 5-hydroxymethyl bond may form before the 1-hydroxymethyl bond.
No crystal data are available for LPO, but the prosthetic group isolated from the digested protein has been identified by NMR and mass spectrometric methods as the 1,5-dihydroxymethyl derivative of heme (5, 6) . The structure of the isolated prosthetic group indicates that in LPO only two ester bonds covalently bind the heme to the protein. Difference Fourier transform infrared studies provide independent evidence that the heme is linked to the protein via ester bonds (7) . A structure model of LPO, constructed by sequence alignment with the MPO template, suggests that Asp-225 is covalently linked to the heme 5-methyl and Glu-375 to the 1-methyl (8) . The involvement of these two residues in cross-linking to the heme has been confirmed by mass spectrometric and sequencing analysis of the fragments obtained from protein digests (9, 10) . The absence of a third cross-link analogous to that in MPO between the vinyl group and a methionine agrees with the fact that the spectrum of LPO, unlike that of MPO, is not shifted due to conjugation of the sulfonium-substituted vinyl group with the porphyrin (2, 3, 11) .
In an earlier communication (6) we demonstrate that the heme in the LPO heterologously expressed in a baculovirus system is only partially covalently attached. Furthermore, we demonstrate that incubation of the recombinant protein with low amounts of H 2 O 2 increased both the extent of covalent heme binding and the catalytic activity (6) . These results provide strong evidence that the heme-protein bonds are formed through a self-processing mechanism. Subsequent studies with EPO showed that the light and heavy chains were not crosslinked in the majority of the isolated protein (10) . In EPO the heme is linked to Asp-93 and Glu-241, one of which is in the heavy, and the other, in the light chain of the mature enzyme (10) . Treatment of the protein with H 2 O 2 increased cross-linking of the chains, in accord with the hypothesis that the heme had only formed a link to one of the two non-cross-linked chains rather than the usual link to both. The formation of the interchain cross-link thus provided evidence that in EPO the heme cross-linking reaction was also an autocatalytic process. Finally, although cross-linking of the heme in thyroid peroxidase has not been unambiguously demonstrated, it has been shown that exposure to H 2 O 2 is important for the formation of mature, active protein (12). This provides indirect evidence that autocatalytic formation of the heme-protein cross-links probably also occurs in thyroid peroxidase.
In the present paper, we address three questions. (a) How stringent are the conformational requirements for proper formation of the ester cross-links? (b) Is the double covalent link important for catalytic activity? (c) Is formation of the two cross-links a sequential or random process? The results shed light on the processing of LPO that is relevant to formation of the mature forms of all the mammalian peroxidases.
EXPERIMENTAL PROCEDURES
General-Sf9 cells (Invitrogen) were grown in Excell 420 (JRH Biosciences), and Hi5 cells were grown in Express Five (Invitrogen) supplemented with glutamine according to the manufacturer's instructions. Both cell lines were kept in suspension at 28°C and maintained at densities between 0.5 ϫ 10 6 and 2 ϫ 10 6 cells/ml. All reactants were purchased from Sigma unless otherwise noted, and all experiments were performed at room temperature unless otherwise stated. Iron(III) 8-hydroxyprotoporphyrin IX was isolated from phenylhydrazinetreated horseradish peroxidase as reported (13) . UV-visible spectra and ABTS-oxidizing activities were recorded on a Hewlett Packard 8452A diode array spectrophotometer, and HPLC analyses were performed on a Hewlett Packard 1090 instrument. The HPLC was equipped with a UV-visible diode array detector, and the reactions were monitored at 215, 280, and 400 nm. Glass reaction vessels were siliconized when needed using Sigmacote. After allowing the vessels to stand for 2-3 min with the manufacturer's solution, the vessels were rinsed twice with hexane and once with acetone and, finally, air-dried.
Cloning and Expression-The bovine LPO gene (2.1 kilobases) including the secretion signal sequence was cloned in the EcoRI cloning site of the baculovirus pACGP67B expression vector (Pharmingen, San Diego, CA) through introduction of this restriction site at positions 120 and 2262 of the bovine LPO gene. The D225E and E375D mutants were obtained by overlap extension PCR, the first by substituting a C for a G at position 797 and the second by substituting a G for a C at position 1247. The double mutant was obtained by two successive overlap extension PCR steps. The resulting constructs were amplified in the DH5␣ Escherichia coli strain, and the nucleotide sequence was verified by complete sequencing of the insert. Co-transfection was performed using the BaculoGold (Pharmingen) transfection kit according to the manufacturer's instructions. Viral stocks were generated and amplified from single virus populations according to established procedures (14) . Hi5 cells were infected at a density of 2.10 6 cells/ml using a multiplicity of infection of ϳ4. At the time of infection, a freshly prepared hemin solution was added (final concentration 6 M) along with penicillin (final concentration 100 units/ml) and streptomycin sulfate (final concentration 100 g/ml).
Purification-Cell suspensions were harvested 2.5 days post-infection and centrifuged at 4°C for 1 h at 10,000 rpm. The supernatant was diluted with an equal volume of double-distilled water, after which protease inhibitors were added at the following final concentrations: phenylmethylsulfonyl fluoride, 200 mg/liter; N-␣-p-tosyl-L-lysine chloromethyl ketone (TLCK), 75 mg/liter; benzamidine, 380 mg/liter; antipain and leupeptin, 5 mg/liter. After stirring for 10 min, batch purification was carried out as follows. Amberlite CG50 cation exchange resin pre-equilibrated in 50 mM Tris.HCl (pH 7.4) was added in three portions over 2 h (ϳ20 ml of settled resin/liter of supernatant). After decantation, the slurry was transferred to a column, and the settled beads were washed first with ϳ5 volumes of 50 mM Tris.HCl and then with ϳ3 volumes of 150 mM Tris.HCl. The pH of both buffers was 7.4 and did or did not contain 0.5 mM CaCl 2 . The CaCl 2 was only employed in one purification of the D225E mutant, used to show that it eliminates the cytochrome c-like contaminant. The protein was finally eluted with 500 mM Tris.HCl at the same pH. The fractions containing material absorbing at 412 nm were pooled and diluted 10-fold with double-distilled water containing or not, as indicated in the text, 0.5 mM CaCl 2 . The resulting solution, which was sometimes turbid, was chromatographed over a CL-6B cation exchange column (2-3 ml of resin/liter of culture). At the end of the loading, the column was washed with ϳ50 volumes of 50 mM Tris.HCl then ϳ50 volumes of 100 mM Tris.HCl, both at pH 7.8, containing or not 0.5 mM CaCl 2 as indicated in the text. Elution was achieved with a linear gradient of KCl (0 -0.3 M, ϳ8 column volumes). Fractions were checked for activity and absorbance at both 280 and 412 nm. Even in the case of the double mutant, residual activities were high enough to allow unequivocal identification of the LPO-containing fractions. Selected fractions were then pooled and concentrated to at least 2 mg/ml by ultrafiltration over Amicon™ YM30 membranes.
Spectrophotometric Measurements-Activities were followed at 414 nm in 50 mM acetate buffer (pH 4.5) in the presence of 250 M ABTS and 125 M H 2 O 2 , both from freshly prepared stock solutions. Specific activities were calculated using the values ⑀ ϭ 38,000 liters/mol/cm (oxidation product of ABTS) and ⑀ ϭ 113,000 liters/mol/cm at 412 and 280 nm (LPO), M r ϭ 78 kDa for nLPO and 73 kDa for all rLPOs, independently of the number of ester bonds between the apo-enzyme and the cofactor. Activities were expressed in mol of ABTS/min/nmol of enzyme. In the case of highly active samples (wild type and E375D mutant), the enzymes were diluted to the necessary concentration in 5 mg/ml bovine serum albumin to limit enzyme losses through nonspecific adsorption. UV-visible spectra of whole samples were recorded in 0. ) was added in single equivalent portions every 3 min. The reaction media was further incubated for 10 min and was then analyzed. For the experiment described in Fig. 6 , the H 2 O 2 treatment was carried out in siliconized reaction glass microvessels.
Pronase Digestion-Protein samples, pretreated with H 2 O 2 or not, at a 1 mg/ml concentration in 0.1 M bis-Tris propane buffer (pH 8.2) were made 1 mM in CaCl 2 . A freshly prepared solution of trypsin (20 mg/ml, 1:5, w/w) was then added, and the mixture was incubated for ϳ3 h at 37°C. The CaCl 2 concentration was then raised to 3 mM, a freshly prepared 20 mg/ml Pronase solution was added (1/5, w/w), and the incubation was prolonged for a further 20 h. Samples were then made 15% in acetonitrile and 0.5% in trifluoroacetic acid and were injected onto the HPLC. For the experiment described in Fig. 6 , the whole digestion procedure was performed in siliconized glass microvessels.
HPLC Analysis-Protein and porphyrin separations were achieved on a 214TP5415 reversed phase C 4 analytical column (Vydac, Hesperia, CA) using 0.1% trifluoroacetic acid in double-distilled water and 0.085% trifluoroacetic acid in acetonitrile (Fisher) as mobile phase components at a flow rate of 1 ml/min. A linear gradient of 0.85%/min starting at t ϭ 3 min and 25% (undigested samples) or 15% (Pronase-digested samples) was used. In the latter case, the compounds eluting from the column were repetitively collected in siliconized glass tubes and concentrated through gentle heating under a stream of N 2 . These solutions were never allowed to dry out. For separation of the 5-and 8-hydroxyhemes, the same column and mobile phase were used, except that a gradient of 0.2%/min starting at 30% was employed. Under these conditions, 5-hydroxyheme eluted at 10.4 min and 8-hydroxyheme at 10.7 min.
Liquid Chromatography/Mass Spectrometry Analysis-Molecular masses were determined by liquid chromatography coupled with electrospray ionization mass spectrometry. Liquid chromatography was performed on an Applied Biosystems HPLC instrument (solvent delivery system 1408, programmable absorption detector 785A) equipped with a 214TP51 reversed phase C 4 capillary column (Vydac, Hesperia, CA) with 1% HCO 2 H in double-distilled water and 1% HCO 2 H in acetonitrile (Fisher) as the mobile phase components (flow rate 40 l/min). A 2%/min linear gradient (20 -60%) was used, and detection was performed at 215 nm. In-line mass measurements were undertaken on a Perseptive Biosystems Mariner Biospectrometry Work station in a positive ion polarity mode with the following settings: spray potential, 2600 -2700 V; nozzle potential, 125 V; 20 scans/min; flow rate 5 l/min; acquisition range 300 -2000 mass units. Calibration was achieved using a gramicidin standard.
Molecular Modeling-Representations of the LPO molecular model are based on the coordinates of De Gioia et al. (8) and were obtained with RasMol.
RESULTS
Expression and Purification-The enzymes were produced with the baculovirus system previously developed for expression of the wild-type enzyme (6). The viral particle yield after three amplification stages was essentially independent of the mutation in the protein, and titrating the final suspensions by plaque assay repeatedly gave titers of ϳ 1 ϫ 10 8 plaque-forming units/ml. However, although the E375D mutant was expressed as efficiently as wild-type rLPO, both the D225E and D225E/E375D mutants were consistently obtained in lower yields (Table I ) and were more sensitive to spontaneous degradation during expression and purification. The addition of protease inhibitors during the entire purification procedure helped to improve both the yield and final purity of the proteins. The wild-type and recombinant enzymes could be stored at Ϫ20°C for prolonged periods without serious loss of activity.
Polyacrylamide gel electrophoresis of the purified recombinant enzymes indicated that they all have a molecular mass of ϳ73 Ϯ 2 kDa (Fig. 1A) , a value considerably lower than the 78 kDa of nLPO (Fig. 1A, lane 1) . The difference in these values indicates that the recombinant proteins are glycosylated to a much lower extent than the native enzyme. A lower extent of glycosylation has also been reported for LPO expressed in Chinese hamster ovary cells (15) and in a baculovirus-insect cell system (16) as well as for the heterologous expression of MPO (16, 17) . A small impurity at ϳ50 kDa in our recombinant proteins was difficult to remove but did not interfere with the subsequent studies. Further purification to remove the impurity was therefore not carried out on a routine basis. In the case of the D225E and D225E/E375D mutants, a low molecular weight (M r ϭ 14.5 kDa) contaminant reproducibly co-purified with the protein (not seen in Fig. 1A , indicated by the asterisk in Figs. 2 and 3 ). This low molecular weight contaminant contained a covalently bound heme but did not derive from LPO and was probably a fragment of cytochrome c from the insect cells. When isolated, this fragment showed no detectable peroxidatic activity. The addition of 0.5 mM CaCl 2 during the whole purification procedure eliminated this component but also significantly decreased the yield of the proteins.
As shown in Table I , rLPO and its mutants exhibited an absorption maximum at 412 nm identical to that of nLPO except for the D225E mutant, which had a slightly red-shifted Soret band at 415 nm. The unperturbed absorption maxima indicate that the mutations had little effect on the heme coordination sphere and environment.
In contrast, the RZ value, a measure of the iron porphyrin content of the proteins, was very sensitive to mutation of the residues to which the heme is attached. Wild-type rLPO gives an RZ value of 0.85 that is very similar to that of nLPO and, thus, compares favorably with that obtained with other LPO expression systems (14, 15) , but the E375D mutant has an RZ value reduced by 35% and the D225E mutant by 44%. The severely depressed RZ ϭ 0.09 value for the double mutant indicates that this protein has very little heme bound at all, in agreement with the fact that its Soret band is barely above the base line. As expected and as indicated by the sharpness of the Soret bands, the purification procedure, which includes two cation-exchange chromatographic steps and one ultrafiltration, removes nonspecifically bound heme from the proteins.
The ABTS oxidation activities qualitatively follow the same pattern as the RZ values. The wild type has a specific activity somewhat lower than nLPO, the E375D mutant ϳ65% that of the wild-type, and the D225E an activity some 60-fold lower than that of the wild type. The D225E/E375D mutant has almost no activity, in agreement with its very low heme content.
HPLC Analysis-The purified recombinant proteins and nLPO were injected onto a C 4 HPLC column under conditions that separate non-covalently bound porphyrins from those covalently attached to the protein (Fig. 2) . Under these conditions, free heme derivatives and heme-bound LPO peptides have an absorption maximum that is shifted to ϳ400 nm, as reported (9) . In the case of nLPO, the trace of the protein at 280 nm and of the porphyrin at 400 nm match very closely with a single peak at 29.5 min (HPLC RZ ϭ 1.3). The heme cofactor in the native enzyme, as expected, is quantitatively bound in a covalent manner to the protein. In the case of wild-type rLPO, the major peak eluting at 29.7 min also absorbs at both wavelengths (HPLC RZ ϳ 0.9). In agreement with our previous observations (6), a free peak attributable to unmodified heme was detected at 20.1 min. These results indicate that in the recombinant wild-type enzyme only a portion of the cofactor is covalently bound to the protein. The ratio of the areas at 400 nm of the peaks at 20.1 and 29.7 min indicates that approximately one-third of the heme is not covalently bound. The E375D mutant, in addition to the free heme peak at 20.1 min, gives a protein-bound heme peak with the slightly shifted retention time of 28.5 min. Approximately 65% of the heme was not covalently bound, and the HPLC RZ for the protein-bound peak was ϳ0.5.
The elution profile of the D225E mutant is somewhat more complex. Apart from a minor peak at ϳ14 min due to the already-mentioned insect cytochrome c-like protein and a small free heme peak, the protein as measured at 280 nm reproducibly eluted as two partially resolved peaks at 30.0 and 31.5 min. The earliest peak, hence, had a retention time similar to those for nLPO and wild-type rLPO but had very little 400-nm absorbance associated with it, whereas the second peak had an HPLC RZ of ϳ1.1, similar to that obtained with nLPO, but eluted 1.5 min later. The D225E mutant is thus present as two separable enzyme populations, one fully loaded with the cofactor and the other almost completely devoid of it.
HPLC analysis of the double mutant indicates the presence of a weak free-heme peak and a single protein peak at 28.5 min with virtually no covalently attached heme, as expected from the low RZ value for the protein. covalently bound heme, a finding that implicated an autocatalytic mechanism for covalent attachment of the prosthetic group (6). We have therefore investigated the behavior of the recombinant proteins toward mild H 2 O 2 treatment. Preliminary experiments showed that treating the wild type and E375D mutants with four eq of H 2 O 2 effectively increased the extent of covalent heme binding (data not shown). The four recombinant enzymes and nLPO were therefore incubated with H 2 O 2 under these conditions, and the changes in the extent of covalent heme attachment, iron porphyrin pattern, and activity were determined.
SDS-PAGE shows that the H 2 O 2 -treated proteins did not undergo any detectable modification as a result of reaction with the peroxide (Fig. 1B, compare with Fig. 1A ). Mild oxidative treatment clearly did not result in protein cleavage or other gross structural alterations. Under the conditions of these studies, a small amount of oligomerization was observed with nLPO and a trace with wild-type rLPO but none with the mutant proteins. The low extent of oligomerization of nLPO and rLPO contrasts with the extensive oligomerization observed under other experimental conditions (18) .
The specific activities of wild-type and E375D rLPO are increased by preincubation with H 2 O 2 by 27 and 370%, respectively (Table II) . Analogous pretreatment of the D225E mutant does not alter its specific activity. In contrast, the very low specific activity of the double mutant is decreased by 40% and that of the native enzyme by 20%, following peroxide pretreatment. It is notable that the final specific activities of the wildtype and E375D mutant are comparable with each other and only a little lower than that of the native enzyme.
HPLC analysis of the H 2 O 2 -treated samples showed that the retention times of the proteins remained unchanged (Fig. 3) , in accord with their unaltered migration on SDS-PAGE (Fig. 1B) . However, for both the wild type and E375D mutant, the 400-nm absorbance associated with the protein peak increased markedly at the expense of the absorbance associated with the free-heme peak, which virtually disappears. The HPLC RZ values for the eluted proteins were similar to the value of ϳ1.2 obtained earlier for nLPO. This observation demonstrates that the amount of non-covalently bound heme present in the wildtype and E375D proteins is sufficient to give a final stoichiometry of approximately one molecule of heme per molecule of protein.
In contrast, no significant changes were observed in the HPLC traces for the D225E and D225E/E375D mutants as a result of H 2 O 2 pretreatment. This is not unexpected, as the HPLC analysis of the untreated enzymes indicated that they contained very little non-covalently bound heme and, therefore, very little heme that could be covalently incorporated into the active site. The H 2 O 2 treatment was therefore repeated in the presence of increasing amounts of added hemin, but no increase in catalytic activity was observed, and the slight increase in covalently bound heme that was detected resulted from nonspecific covalent binding (data not shown). The asterisk indicates the peak due to the cytochrome c-like impurity (see under "Results"). For the D225E mutant, the spectrum in the dotted line is for the species eluting at 30.0 min, and that in the solid line is for the species eluting at 31.5 min. The rising absorbance at the end of the run is due to material eluted in the column wash.
Iron Porphyrin Distribution-To further study the effect of mutating Glu-375 and Asp-225 on cross-linking of the heme to the protein, the number and position of the covalent links to the heme in each protein was investigated. Previous work has shown that digestion with Pronase leads to partial liberation of the prosthetic group from nLPO (6, 19, 20) , but a later study reported higher efficiency with the combined use of two proteases (9) . Optimization of the conditions (not shown) led us to the combined use of trypsin and Pronase at pH 8.2 in the presence of CaCl 2 but the absence of added reductant. These conditions, which result in a very efficient liberation of peptidefree heme derivatives, were employed with all the proteins except the D225E/E375D mutant, which had virtually no covalently bound heme. The digested solutions were then directly injected onto the HPLC, and species with a porphyrin-like UV-visible spectrum were collected and analyzed by electrospray mass spectrometry.
The HPLC traces and the UV-visible spectra of the collected peaks are presented in Fig. 4 , A and B, respectively. The slight solvent-dependent red shift already mentioned was also seen here. Digestion of the native enzyme gives a single species at 17.5 min with a molecular weight of 648 atomic mass units. Previous work has identified this compound as 1,5-dihydroxy heme or, more precisely, iron(III) 1,5-dihydroxymethylprotoporphyrin IX (6, 7, 9 for the commercial and purified recombinant enzymes are shown, and the corresponding UV-visible spectra are presented to the right of each trace. The asterisk indicates the peak due to the cytochrome c-like impurity (see under "Results"). For the D225E mutant, the spectrum in the dotted line is for the species eluting at 30.0 min, and that in the solid line is for the species eluting at 31.5 min. The rising absorbance at the end of the run is due to material eluted in the column wash. One of these eluted at 17.5 min (648 atomic mass unit, 5% relative intensity) and corresponded to the 1,5-dihydroxyheme peak obtained with nLPO. The second minor peak eluted at 25.6 min (632 atomic mass unit, 25% relative intensity) and had all the characteristics of a monohydroxylated heme derivative. However, its elution time is clearly different from that of the monoxyhydroxy derivative obtained from wild-type rLPO (25.6 versus 23.8 min), so the two monohydroxylated hemes are distinct entities. Upon H 2 O 2 treatment of the E375D mutant, the monohydroxylated heme species increased at the expense of the free heme peak, whereas the 1,5-dihydroxyheme peak only increased slightly.
Digestion of the D225E mutant, whether treated with H 2 O 2 or not, yielded a single detectable heme species at 23.8 min. The intensity of this peak was not altered by incubation with H 2 O 2 . Its retention time and molecular mass (632 atomic mass unit) identify it as the same monohydroxy derivative as was obtained from the wild-type protein. The peak eluting at 15.7 min in the chromatogram (denoted by the asterisk in Fig. 4A ) is the cytochrome c-like contaminant. Isolation and separate digestion of this contaminant under the same conditions only gave back the same 15.7-min peak, so the contaminant did not interfere with the proteolytic analysis. As a further test of the product structures, co-injection of the two monohydroxy derivatives with elution times of 23.8 and 25.6 min with authentic iron(III) 8-hydroxymethylprotoporphyrin IX showed that the hydroxyl group was not on the 8-methyl group in either of the monohydroxylated heme derivatives. The 8-hydroxylated standard was prepared as previously reported (13) . Thus, four heme derivatives are obtained from the recombinant proteins; they are heme and 1,5-dihydroxyheme (rLPO and E375D mutant) and two different monohydroxylated hemes that elute, respectively, at 23.8 min (wild type and D225E mutant) and 25.8 min (E375D mutant), neither of which is the 8-hydroxyheme derivative.
To better define the relationship between the nature of the heme group and peroxide treatment, the E375D mutant was treated with various amounts of H 2 O 2 , the activity of the protein was measured, and the heme species present in the protein were quantitatively determined by digestion and HPLC analysis (Fig. 5) . H 2 O 2 treatment of the E375D mutant triggered a rapid disappearance of the parent heme that is matched by a sharp initial increase in the monohydroxylated derivative and a parallel rise in catalytic activity. The proportion of 1,5-dihydroxyheme also increased but to a much lower extent. As the number of added H 2 O 2 equivalents exceeds 2, the proportion of the dihydroxylated species increased as that of the monohydroxylated heme decreases. The surprising finding, however, is that the specific activity actually decreases at the higher peroxide concentrations, where the 1,5-dihydroxyheme content increases at the expense of that of the monohydroxylated heme. When the enzyme treated with 10 eq of H 2 O 2 , which exhibited a Soret band at 416 nm just after treatment, was treated with a limited amount of potassium ferrocyanide, the Soret band shifted back to 412 nm. The sample thus obtained, when treated again with 10 eq of H 2 O 2 , showed a further increase in the proportion of the dihydroxylated heme derivative to 40% of the total heme. However, this increase in double cross-linked heme was not associated with a change in the catalytic activity (data not shown).
DISCUSSION
Although the recombinant wild-type protein is less glycosylated than the native protein and therefore has a lower molecular mass (Fig. 1A) , the similarities in the spectroscopic, structural and catalytic properties of the recombinant and native enzymes indicate that the glycosylation pattern is not critical for enzyme function. The recombinant wild-type enzyme has an RZ value comparable with that of nLPO but a lower specific activity (Table I ). This result is paralleled by the fact that only 65-70% of the total heme content in wild-type rLPO is covalently bound to the protein and is in accord with previous results (6) . Complete digestion of the enzyme, which releases the prosthetic group, shows that the major component in rLPO is the same 1,5-dihydroxyheme that is found in nLPO. Two minor components were also detected and were identified as unmodified heme and a monohydroxylated heme. As reported previously (6, 14) , mild H 2 O 2 treatment causes a ϳ27% increase in the specific activity. We establish here that this treatment also converts virtually all of the heme and monohydroxyheme species into a single covalently bound derivative that is released by proteolysis as 1,5-dihydroxyheme. This finding suggests that the monohydroxyderivative is either the 1-or 5-hydroxylated derivative of iron(III)-protoporphyrin IX and is either an intermediate or side product of the double crosslinking process. No significant amount of any other heme derivative has been detected in the wild-type rLPO hydrolysates. The observation of only one of the two expected monohydroxy heme derivatives suggests that the cross-linking pathway follows an ordered sequence in which one methyl group of the heme is covalently bound (hydroxylated) before the other (Scheme 1).
Replacement of an aspartate by a glutamate or vice versa is a conservative substitution with respect to side-chain hydrophobicity, pK a , and charge. The only substantive change in such a replacement is the difference of one methylene unit in the length of the side chain. Nevertheless, the D225E and E375D mutations differentially alter the properties of rLPO. The HPLC traces of rLPO and nLPO were very similar, but reproducible differences were observed in the elution times of the three rLPO mutants. The E375D and D225E/E375D mutants eluted ϳ1 min earlier than the wild-type enzyme, whereas the D225E mutant eluted as two distinct protein peaks, one without heme, that had the same elution time as the wild-type, and a second heme-bound species ϳ1.5 min later. The observation of these two D225E protein peaks is notable in view of the fact that only one HPLC peak is observed for both heme-free and heme-bound proteins with rLPO and its E375D mutant. It is unclear why covalent heme binding alters the protein properties to a larger extent in the D225E than E375D mutant, although we cannot exclude the possibility that two forms of the protein are present, only one of which has bound the heme group. Whatever differences are reflected in the HPLC elution times of the denatured D225E mutant components, the fraction that binds the heme group does not appear to be greatly perturbed in the folded state, as its Soret maximum differs by only 3 nm from that of the other proteins (Table  I) . It is perhaps interesting in this context that mutating Asp-94 in MPO also resulted in the observation of two protein species (21) .
The D225E mutation arrested ester bond formation after a single cross-link was forged. Only one monohydroxyheme derivative was obtained after digestion of the protein, and this derivative was the same as the one isolated as a minor component from wild-type rLPO. No other hydroxylated heme was detected in the proteolytic digestion. If one assumes that a mutation will impair ester formation at the mutated site rather than at the alternative carboxyl site, mutating Asp-225 hinders formation to the 5-hydroxyheme cross-link. The single monohydroxylated derivative isolated from the D225E mutant can therefore be identified as Fe(III) 1-hydroxymethylprotoporphyrin IX, an assignment consistent with its spectrum, polarity, mass spectrometric molecular mass, and non-identity with the 8-hydroxymethyl derivative.
The sensitivity of the protein to Asp-225 mutations may reflect the critical position of this residue in the protein sequence. His-226, the adjacent residue, is the critical acid-base catalyst, and Asp-227, the subsequent residue, has been proposed to be part of the LPO calcium binding site (22, 23) . The catalytic action of the protein and formation of the double heme cross-link may therefore be particularly sensitive to even small structural perturbations in this region of the protein. The formation of a single bond between the protein and the heme has a precedent in EPO, for which it has been reported that roughly two-thirds of the native enzyme has the heme attached through a single ester bond, and the other third, through two ester bonds (10). Exposure of EPO to H 2 O 2 , as first demonstrated for rLPO and confirmed here (6) , results in complete double crosslinking of the heme prosthetic group.
Mutating Glu-375 less dramatically decreased the RZ value and specific activity (ϳ65 and ϳ35%, respectively) than mutating Asp-225. Furthermore, incubation of the enzyme with 2 eq of H 2 O 2 yielded an enzyme with a heme content and activity similar to that of the wild-type enzyme (Table II) . The LPO active site is, thus, more tolerant to structural perturbation in the vicinity of the 1-than 5-methyl group of the heme. The porphyrin distribution pattern before and after treatment with H 2 O 2 differed from that of the wild-type enzyme. In the untreated E375D mutant, the porphyrin species were unmodified heme (70%), a small amount of 1,5-dihydroxyheme (5%), and a new monohydroxy heme derivative (25%). The new monohydroxylated species is 5-hydroxyheme, because it differs from the 1-hydroxyheme species from the D225E mutant, differs from authentic 8-hydroxyheme, and is the ester product expected when Glu-375 is mutated in the LPO structure model. Incidentally, the non-identity with 8-hydroxyheme shows that the heme in the E375D mutant is not inserted in an orientation that is flipped by 180°around its meso ␣-␦ axis. In contrast to the D225E mutant, incubating the E375D mutant with 2 eq of H 2 O 2 converted the unmodified heme in the enzyme almost completely to the monohydroxy derivative (Fig. 4) , and incubation with excess H 2 O 2 partially converted the monohydroxy heme into the dihydroxylated species (Fig. 5) . These observations imply that the monohydroxyheme is an intermediate in formation of the double cross-link. Clearly, with the E375D mutant, the first bond formed is that between Asp-225 and the 5-methyl of the heme. The leveling off of the proportion of the dihydroxylated heme formed at ϳ30% of the total when more than 10 eq of H 2 O 2 were added can be explained by conversion of the LPO with a single heme cross-link to a metastable compound II or III species by reaction with the excess H 2 O 2 in the absence of any reductant. Indeed, the shift in the absorption maximum from 416 to 412 nm upon reduction shows that the H 2 O 2 -treated E375D mutant was in an oxidized state. Thus, in the absence of a reductant that can return the enzyme to the ferric state, no further reaction with H 2 O 2 and, consequently, no further ester bond formation is possible. The observation of a further increase in the proportion of the monohydroxy heme derivative when the enzyme was reduced before exposure to additional H 2 O 2 is consistent with this proposal.
The vast majority of the active site residues are conserved among LPO, MPO, and EPO, which suggests that the active site architecture is strongly conserved in this family of proteins (8) . A notable exception is the three residues after Glu-375; in bovine LPO they are QIL, in human EPO they are TPK, and in human MPO they are MPE. In the LPO structural model, Glu-375 is located at the top of a loop, pointing toward the 1-methyl carbon of the cofactor and appears to be in a less congested and rigid environment. The only other catalytically important residue in its immediate vicinity is Arg-372, which is three residues away. The other elements surrounding the 1-methyl substituent are two short helixes (492-498 and 529 -539) and a longer helix (549 -560) connected by a loose loop to SCHEME 1. Possible reaction pathways for the formation of the covalent bonds between the protein and the heme in LPO. R ‫؍‬ (CH 2 ) 2 COOH.
an additional very short helix (residues 491-498). These helices should provide a very hydrophobic environment above the plane of the heme. In contrast, the B-C edge of the tetrapyrrole ring is sandwiched between two roughly parallel helixes spanning residues 214 -229 and 457-469 that contain Asp-227, which is a part of the putative calcium binding site, His-226, the catalytic histidine, His-468, the proximal iron ligand, and Arg-465. The equivalent residue to Arg-465 in MPO is Arg-499, a residue in direct ionic contact with the C-ring propionate side chain. This very compact and probably fairly rigid assembly leaves little room around Asp-225 and supports the conclusion that formation of the ester bond at this site is relatively sensitive to mutations (Fig. 6) . In general, the environment surrounding Glu-375 in the structural model appears to be more tolerant than that around Asp-225.
The data in Fig. 5 show that in the E375D mutant, unmodified heme is present in the mutant, and maximum activity is obtained upon treatment with H 2 O 2 when the proportion of the singly bound 5-hydroxyheme is highest. Increasing the H 2 O 2 to 20 eq increases the amount of doubly bound heme at the expense of the singly bound while decreasing the catalytic activity. In contrast, only a limited amount of heme is bound in the D225E mutant and that through a single ester bond to the 1-methyl group. Furthermore, treatment with increasing amounts of H 2 O 2 does not give rise to any doubly linked heme. These results suggest that covalent bond formation to the 5-methyl has less stringent requirements than to the 1-methyl (Scheme 1). It is therefore possible that the 5-methyl bond is normally formed faster. The 5-hydroxyheme bond is formed first in the E375D mutant, and then the second cross-link is readily formed with excess H 2 O 2 , even though this requires attachment to the shortened carboxyl chain at position 375. In contrast, in the D225E mutant, some heme is bound as a monoester to the 1-methyl group, but it is unable to form the second cross-link on exposure to excess H 2 O 2 .
Three conclusions follow from these studies. First, a noncovalently bound heme in the LPO active site, whether mutated or not, can react with H 2 O 2 to give a reactive species that promotes reaction of the 1-and 5-methyl groups with nearby carboxylic side chains. A covalent bond need not be present to allow the heme to be regio-and chemo-selectively oxidized. Second, a single link between the enzyme and the heme cofactor is enough to produce a fully functional protein. Third, because the singly bound heme in the D225E mutant is not able to forge the second link, its formation represents a dead-end process in the mutant. Failure to form this second link could be due either to an inherent difficulty per se in forming that bond after the Glu-375 bond or/and a difficulty introduced by extending the carboxylate side chain at position 225 in the D225E mutant.
